Correlation Between Coda Octopus and Estrella Immunopharma

Can any of the company-specific risk be diversified away by investing in both Coda Octopus and Estrella Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coda Octopus and Estrella Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Coda Octopus Group and Estrella Immunopharma, you can compare the effects of market volatilities on Coda Octopus and Estrella Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coda Octopus with a short position of Estrella Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coda Octopus and Estrella Immunopharma.

Diversification Opportunities for Coda Octopus and Estrella Immunopharma

-0.11

Correlation Coefficient

Coda Octopus  Estrella Immunopharma

Good diversification

The 3 months correlation between Coda and Estrella is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Coda Octopus Group and Estrella Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Estrella Immunopharma and Coda Octopus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coda Octopus Group are associated (or correlated) with Estrella Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Estrella Immunopharma has no effect on the direction of Coda Octopus i.e., Coda Octopus and Estrella Immunopharma go up and down completely randomly.

Pair Corralation between Coda Octopus and Estrella Immunopharma

Given the investment horizon of 90 days Coda Octopus Group is expected to under-perform the Estrella Immunopharma. But the stock apears to be less risky and, when comparing its historical volatility, Coda Octopus Group is 7.07 times less risky than Estrella Immunopharma. The stock trades about -0.13 of its potential returns per unit of risk. The Estrella Immunopharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  9.19  in Estrella Immunopharma on December 20, 2024 and sell it today you would lose (0.80) from holding Estrella Immunopharma or give up 8.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	55.0%
Values	Daily Returns

Coda Octopus Group  vs.  Estrella Immunopharma

Coda Octopus Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Coda Octopus Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Estrella Immunopharma

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Estrella Immunopharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Coda Octopus and Estrella Immunopharma

The main advantage of trading using opposite Coda Octopus and Estrella Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coda Octopus position performs unexpectedly, Estrella Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Estrella Immunopharma will offset losses from the drop in Estrella Immunopharma's long position.

The idea behind Coda Octopus Group and Estrella Immunopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.